Skip to main content
Testing version — LOERadar is in active testing. Features and data may change.
LOERadar
LOE
Radar
Hub
News
Changes
Search
Log in
Get Started
FETROJA (CEFIDEROCOL SULFATE TOSYLATE) | LOERadar
Viewing data from:
Latest
2026-07-01
2026-06-01
2026-05-01
2026-04-01
2026-03-28
2026-02-17
2026-02-10
2025-12-14
2025-02-26
2025-01-25
2024-11-08
2023-07-23
2023-06-15
2023-05-13
2023-01-26
2022-11-22
2022-10-28
2022-09-29
2022-07-09
2022-06-29
2022-04-08
2022-03-09
2021-12-28
2021-05-05
2021-03-12
2020-12-22
2020-11-12
2019-12-14
2019-09-15
FETROJA
NDA
Get alerts
CEFIDEROCOL SULFATE TOSYLATE | N209445 | SHIONOGI INC
1 strength
3 unique patents
2 unique exclusivities
Patents
SEC Intel
Revenue
PTAB
Reexams
Litigation
Petitions
Trials
Price Trends
Medicare D
Medicare B
Approvals
Label
Products
Patent Timeline
3 unique patents, 2 exclusivities by expiration date
Active (3)
Today
Exclusivity
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
Today
9238657
Nov. 14, 2033
9949982
Sep. 3, 2035
10004750
Sep. 3, 2035
NCE
Nov. 14, 2024
GAIN
Nov. 14, 2029
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — EQ 1GM BASE/VIAL
RLD
3 patents
2 exclusivities
▴
POWDER;INTRAVENOUS | Approved: Nov 14, 2019
Patents (3)
Patent #
Expiration
PED
Drug Substance
Drug Product
Use Code
Delist
9238657
Nov 14, 2033
—
Yes
Yes
U-282
METHOD OF TREATING BACTERIAL INFECTIONS
—
9949982
Sep 3, 2035
—
—
Yes
—
—
10004750
Sep 3, 2035
—
Yes
Yes
—
—
Exclusivities (2)
Code
Date
Status
GAIN
Nov 14, 2029
Active
NCE
Nov 14, 2024
Expired